Illinois

Who we are

• April 5, 2022

  A Study of NX-1607 in Adults With Advanced Malignancies

• April 5, 2022

  REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors

• April 5, 2022

  Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

• April 5, 2022

  Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

• April 5, 2022

  CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

• April 5, 2022

  Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients

Previous34